Inhibition of the PI3 kinase/Akt pathway enhances doxorubicin-induced apoptotic cell death in tumor cells in a p53-dependent manner
- 1 February 2006
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 340 (2) , 560-566
- https://doi.org/10.1016/j.bbrc.2005.12.039
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 22 references indexed in Scilit:
- The transcriptional targets of p53 in apoptosis controlBiochemical and Biophysical Research Communications, 2005
- Akt/Protein Kinase B Signaling Inhibitor-2, a Selective Small Molecule Inhibitor of Akt Signaling with Antitumor Activity in Cancer Cells Overexpressing AktCancer Research, 2004
- Doxorubicin Induces Apoptosis in Normal and Tumor Cells via Distinctly Different MechanismsJournal of Biological Chemistry, 2004
- Prolonged Nuclear Retention of Activated Extracellular Signal-regulated Kinase 1/2 Is Required for Hepatocyte Growth Factor-induced Cell MotilityJournal of Biological Chemistry, 2002
- The phosphatidylinositol 3-Kinase–AKT pathway in human cancerNature Reviews Cancer, 2002
- DNA and its associated processes as targets for cancer therapyNature Reviews Cancer, 2002
- Cytometry in cell necrobiology: Analysis of apoptosis and accidental cell death (necrosis)Cytometry, 1997
- Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosisNature, 1995
- p53 proteins accumulated by heat stress associate with heat shock proteins HSP72/HSC73 in human glioblastoma cell linesCancer Letters, 1994
- p53 Status and the Efficacy of Cancer Therapy in VivoScience, 1994